Sergio Cerpa‐Cruz

534 total citations
54 papers, 377 citations indexed

About

Sergio Cerpa‐Cruz is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Sergio Cerpa‐Cruz has authored 54 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 18 papers in Immunology and 11 papers in Epidemiology. Recurrent topics in Sergio Cerpa‐Cruz's work include Systemic Lupus Erythematosus Research (17 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Sergio Cerpa‐Cruz is often cited by papers focused on Systemic Lupus Erythematosus Research (17 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Sergio Cerpa‐Cruz collaborates with scholars based in Mexico, United States and Spain. Sergio Cerpa‐Cruz's co-authors include José Francisco Muñóz-Valle, Isela Parra‐Rojas, Ulises De la Cruz-Mosso, Sergio Gutiérrez‐Ureña, Samuel García‐Arellano, Bárbara Vizmanos, Patricia Paredes-Casillas, Margarita Montoya‐Buelna, Ana Guilaisne Bernard‐Medina and Edsaúl Emilio Pérez-Guerrero and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Sergio Cerpa‐Cruz

45 papers receiving 366 citations

Peers

Sergio Cerpa‐Cruz
Andrea Ottria Netherlands
Shashi Anand India
Yini Ke China
Eduardo Gómez-Bañuelos Mexico
Cristina Costa Duarte Lanna Brazil
Charis F. Meng United States
B. W. Kirkham Australia
Danxia Zheng China
Kenji Yokoi Japan
Andrea Ottria Netherlands
Sergio Cerpa‐Cruz
Citations per year, relative to Sergio Cerpa‐Cruz Sergio Cerpa‐Cruz (= 1×) peers Andrea Ottria

Countries citing papers authored by Sergio Cerpa‐Cruz

Since Specialization
Citations

This map shows the geographic impact of Sergio Cerpa‐Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Cerpa‐Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Cerpa‐Cruz more than expected).

Fields of papers citing papers by Sergio Cerpa‐Cruz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Cerpa‐Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Cerpa‐Cruz. The network helps show where Sergio Cerpa‐Cruz may publish in the future.

Co-authorship network of co-authors of Sergio Cerpa‐Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Cerpa‐Cruz. A scholar is included among the top collaborators of Sergio Cerpa‐Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Cerpa‐Cruz. Sergio Cerpa‐Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández‐Bello, Jorge, Horacio Bach, Sergio Cerpa‐Cruz, et al.. (2025). PtpA protein from Mycobacterium avium subsp. paratuberculosis as a potential marker of rheumatoid arthritis in humans. PLoS ONE. 20(1). e0316727–e0316727.
2.
Irazoque-Palazuelos, Fedra, Miguel Ángel Saavedra, Sergio Cerpa‐Cruz, et al.. (2025). Lupus nephritis in Mexican patients: Response to intensive therapy. Reumatología Clínica (English Edition). 21(5). 501896–501896.
3.
4.
5.
Gámez-Nava, Jorge Iván, Sergio Cerpa‐Cruz, Sergio Gutiérrez‐Ureña, et al.. (2023). Complementary Therapies and Their Association with Problems in Therapeutic Adherence to Conventional Synthetic DMARDs in Rheumatoid Arthritis: A Cross-Sectional Study. Healthcare. 12(1). 49–49. 1 indexed citations
6.
Pérez-Guerrero, Edsaúl Emilio, Ana Míriam Saldaña-Cruz, Rocío Ivette López-Roa, et al.. (2022). Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels. Scientific Reports. 12(1). 1877–1877. 4 indexed citations
7.
8.
Gámez-Nava, Jorge Iván, Ana Míriam Saldaña-Cruz, Alfredo Celis, et al.. (2021). Functional disability is related to serum chemerin levels in rheumatoid arthritis. Scientific Reports. 11(1). 8360–8360. 6 indexed citations
9.
Parra‐Rojas, Isela, Bárbara Vizmanos, José Francisco Muñóz-Valle, et al.. (2020). Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study. Clinical Immunology. 222. 108637–108637. 21 indexed citations
10.
Gutiérrez‐Ureña, Sergio, et al.. (2020). Peficitinib hydrobromide to treat rheumatoid arthritis. Drugs of today. 56(8). 505–505. 1 indexed citations
11.
Velasco, J.A. Velarde-Ruiz, et al.. (2019). Extrahepatic complications of non-alcoholic fatty liver disease. SHILAP Revista de lepidopterología. 84(4). 472–481. 4 indexed citations
12.
Velasco, J.A. Velarde-Ruiz, et al.. (2019). Complicaciones extrahepáticas de la enfermedad por hígado graso no alcohólico: impacto más allá del hígado. Revista de Gastroenterología de México. 84(4). 472–481. 12 indexed citations
13.
Cerpa‐Cruz, Sergio, et al.. (2019). Deformación miocárdica de la aurícula izquierda en pacientes con lupus eritematoso sistémico. Reumatología Clínica. 17(2). 74–81. 1 indexed citations
14.
Pérez-Guerrero, Edsaúl Emilio, Laura González-López, José Francisco Muñóz-Valle, et al.. (2018). Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritis. Inflammopharmacology. 26(6). 1375–1381. 9 indexed citations
15.
García‐Arellano, Samuel, Richard Bucala, Mara Anaís Llamas-Covarrubias, et al.. (2018). Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients. Cytokine. 115. 89–96. 16 indexed citations
16.
17.
Cerpa‐Cruz, Sergio, et al.. (2016). Sarcopenia in patients with autoimmune diseases. 136–142. 1 indexed citations
18.
Gutiérrez‐Ureña, Sergio, et al.. (2016). Sarcoidosis peritoneal: Reporte de un caso. 205–216. 1 indexed citations
19.
Cerpa‐Cruz, Sergio, Sergio Gutiérrez‐Ureña, Jorge Hernández‐Bello, et al.. (2016). CD40 functional gene polymorphisms and mRNA expression in rheumatoid arthritis patients from western Mexico. Genetics and Molecular Research. 15(4). 5 indexed citations
20.
Cerpa‐Cruz, Sergio, et al.. (2016). Sarcopenia en pacientes con enfermedades autoinmunes. 136–142. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Ottria Breakdown of academic impact, for papers by Shashi Anand Breakdown of academic impact, for papers by Yini Ke Breakdown of academic impact, for papers by Eduardo Gómez-Bañuelos Breakdown of academic impact, for papers by Cristina Costa Duarte Lanna Breakdown of academic impact, for papers by Charis F. Meng Breakdown of academic impact, for papers by B. W. Kirkham Breakdown of academic impact, for papers by Danxia Zheng Breakdown of academic impact, for papers by Kenji Yokoi
Rankless by CCL
2026